• Preparation and Characterization of Levofloxacin Electrolyte Complex for Eradication of Resistant Helicobacter Pylori

  • Jun Hak Lee# , Sung Mo Park# , Jae Yeol Kim, Chang Soo Lee, Sang Woo Kim, and Kwan Hyung Cho†

  • College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Korea

  • 내성 Helicobacter Pylori 제균 치료를 위한 Levofloxacin 정전기 복합체 제조 및 평가

  • 이준학# · 박성모# · 김재열 · 이창수 · 김상우 · 조관형†

  • 인제대학교 약학대학

  • Reproduction, stored in a retrieval system, or transmitted in any form of any part of this publication is permitted only by written permission from the Polymer Society of Korea.

References
  • 1. Malfertheiner, P.; Camargo, M. C.; El-Omar, E.; Liou, J. M.; Peek, R.; Schulz, C.; Smith, S. I.; Suerbaum. S. Helicobacter Pylori Infection. Nat Rev Dis Primers 2023, 19.
  •  
  • 2. Hooi, J. K. Y.; Lai, W. Y.; Suen, M. M. Y.; Underwood, F. E.; Tanyingoh, D.; Malfertheiner, P.; Graham, D. Y.; Wong, V. W. S.; Wu, J. C. Y.; Chan, F. K. L.; Sung, J. J. Y.; Kaplan, G. G.; Ng, S. C. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology 2017, 153, 420-429.
  •  
  • 3. Li, Y.; Choi, H.; Leung, K.; Jiang, F.; Grajam, D. Y.; Leung, W. K. Global Prevalence of Helicobacter Pylori Infection Between 1980 and 2022: A Systematic Review and Meta-analysis. Lancet Gastroenterology & Hepatology 2023, 8, 553-564.
  •  
  • 4. Kate, V.; Kalayarasan, R; Ananthakrishnan, N. Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication: a Systematic Review of Recent Evidence. Drugs 2013, 73, 815-824.
  •  
  • 5. Fallone, C. A.; Moss, S. F.; Malfertheiner, P. Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics. Gastroenterology 2019, 157, 44-53.
  •  
  • 6. Salahi-Niri, A.; Nabavi-Rad, A. N.; Monahan, T. M.; Rokkas, T.; Doulberis, M.; Sadeghi, A.; Zali, M. R.; Yamaoka, Y.; Tacconelli, E.; Yadegar, A. Global Prevalence of Helicobacter Pylori Antibiotic Resistance Among Children in the World Health Organization Regions Between 2000 and 2023: A Systematic Review and Meta-analysis. BMC Medicine 2024, 598.
  •  
  • 7. Gisbert, J. P.; Pajares, J. M. Helicobacter Pylori “rescue” Therapy After Failure of Two Eradication Treatments. Helicobacter 2005, 10, 363-372.
  •  
  • 8. Gisbert, J. P.; Morena, F. Systematic Review and Meta-analysis: Levofloxacin-based Rescue Regimens After Helicobacter Pylori Treatment Failure. Aliment Pharmacol Ther. 2006, 23, 35-44.
  •  
  • 9. Hurst, M.; Lamb, H. M.; Scott, L. J.; Figgitt, D. P. Levofloxacin. Drugs 2002, 62, 2127-2167.
  •  
  • 10. North, D. S.; Fish, D. N.; Redington, J. J. Levofloxacin, A Second-generation Fluoroquinolone. Pharmacotherapy 1998, 18, 915-35.
  •  
  • 11. Oliphant, C. M.; Green, G. M. Quinolones: A Comprehensive Review. Am Fam Physician 2002, 65, 455-64.
  •  
  • 12. Necas, J.; Bartosikova, L. Carrageenan: A Review. Vet Med-Czech 2013, 58, 187-205.
  •  
  • 13. Li, L.; Ni, R.; Shao, Y.; Mao, S. Carrageenan and Its Applications in Drug Delivery. Carbohydrate Polymers 2014, 103, 1-11.
  •  
  • 14. Antonov, Y. A.; Zhuravleva, I. L. Complexation of Lysozyme With Lambda Carrageenan: Complex Characterization and Protein Stability. Food Hydrocolloids 2019, 87, 519-529.
  •  
  • 15. Tapia, C.; Escobar, Z.; Costa, E.; Sapag-Hagar, J.; Valenzuela, F.; Basualto, C.; Gai, M. N.; Yazdani-Pedram, M. Comparative Studies on Polyelectrolyte Complexes and Mixtures of Chitosan–alginate and Chitosan–carrageenan as Prolonged Diltiazem Clorhydrate Release Systems. Europ. J. Pharm. Biopharmaceutics 2004, 57, 65-75.
  •  
  • 16. Heinen, C.; Reuss, S.; Saaler-Reinhardt, S.; Langguth, P. Mechanistic Basis for Unexpected Bioavailability Enhancement of Polyelectrolyte Complexes Incorporating BCS class III Drugs and Carrageenans. Europ. J. Pharm. Biopharmaceutics 2013, 85, 26-33.
  •  
  • 17. Mocchiutti, P.; Schnell, C. N.; Rossi, G. D.; Peresin, M. A.; Zanuttini, M. A.; Galván, M. V. Cationic and Anionic Polyelectrolyte Complexes of Xylan and Chitosan. Interaction with Lignocellulosic Surfaces. Carbohydrate Polymers 2016, 150, 89-98.
  •  
  • 18. Kindermann, C.; Matthée, K.; Sievert, F.; Breitreutz, J. Electrolyte-Stimulated Biphasic Dissolution Profile and Stability Enhancement for Tablets Containing Drug-Polyelectrolyte Complexes. Pharm. Res. 2012, 29, 2710-2721.
  •  
  • 19. Lankalapalli, S.; Kolapalli, V. R. Polyelectrolyte Complexes: A Review of their Applicability in Drug Delivery Technology. Indian J. Pharm. Sci. 2009, 71, 481-487.
  •  
  • 20. Mónica, C. G.; Julio C. C.; Clarisa I. R.; Paulina L. P.; Miriam C. S.; Ruben H. M.; Fabiana L. A.; Cecilia I. A. I.; Alvaro F. J. K. A Novel Gel Based on An Ionic Complex From a Dendronized Polymer and Ciprofloxacin: Evaluation of Its Use for Controlled Topical Drug Release. Mater. Sci. Eng. C 2016, 69, 236-246.
  •  
  • 21. Yermak, I. M..; Davydova, V. N.; Kravchenko, A. O.; Chistyulin, D. A.; Pimenova, E. A.; Glazunov, V. P. Mucoadhesive Properties of Sulphated Polysaccharides Carrageenans from Red Seaweed Families Gigartinaceae and Tichocarpaceae. Int. J. Biolog. Macromol. 2020, 142, 634-642.
  •  
  • 22. Park, J. W.; Lee, S.-W.; Lee, J. H.; Park, S. M.; Cho, S. J.; Maeng, H.-J.; Cho, K. H. Supersaturated Gel Formulation (SGF) of Atorvastatin at a Maximum Dose of 80 mg with Enhanced Solubility, Dissolution, and Physical Stability. Gels 2024, 10, 837.
  •  
  • 23. Nasrazadani, S.; Eghtesad, R.; Sudoi, E.; Vupputuri, S.; Ramsey, J. D.; Ley, M. T. Application of Fourier Transform Infrared Spectroscopy to Study Concrete Degradation Induced by Biogenic Sulfuric Acid. Mater Struct 2016, 49, 2025-2034.
  •  
  • 24. Maezawa, K.; Yajima, R.; Terajima, T.; Kizu, J.; Hori, S. Dissolution Profile of 24 Levofloxacin (100 mg) Tablets. J. Infection Chemotherapy 2013, 19, 996-998.
  •  
  • Polymer(Korea) 폴리머
  • Frequency : Bimonthly(odd)
    ISSN 2234-8077(Online)
    Abbr. Polym. Korea
  • 2024 Impact Factor : 0.6
  • Indexed in SCIE

This Article

  • 2025; 49(4): 512-517

    Published online Jul 25, 2025

  • 10.7317/pk.2025.49.4.512
  • Received on Apr 2, 2025
  • Revised on Apr 29, 2025
  • Accepted on Apr 29, 2025

Correspondence to

  • Kwan Hyung Cho

  • College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Korea

  • E-mail: Chokh@inje.ac.kr